ArticleEndoscopy international open2026
Device-assisted enteroscopy: With increasing requirements, national Irish data support a centralized high-volume model to achieve performance targets.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From audit to policy: ESGE performance measures in centralized device-assisted enteroscopy services.Endoscopy international open · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and study aims: Device-assisted enteroscopy (DAE) has seen a rapid increase in demand in recent years. European Society of Gastrointestinal Endoscopy (ESGE) DAE key performance indicators (KPIs) have been published as well as some national datasets. Data suggest variation in practice and service provision impacts outcomes. The aim of this study was to review DAE services in Ireland according to ESGE KPIs and wider outcomes. Methods: DAE data from records at Tallaght and Connolly Hospital from January 2015 to May 2024 were retrospectively collated. Results: Overall, 941 studies were included. 798 (85%) were index procedures and 548 (58%) were on men with a mean age of 61. Double-balloon enteroscopy was used in 864 (92%), 745 (79%) were anterograde (ADBE), and 196 (21%) were retrograde (RDBE). Mean depths of insertion were 201 cm ± 101 cm for ADBE and 101 cm ± 67 cm for RDBE. Of the procedures, 868 (92%) used conscious sedation; median doses of midazolam and fentanyl were 5 mg and 75 µg, respectively, with a mean comfort score (Modified Gloucester Scale) of 1.45 ± 0.67. Overall yield was 63%. Therapeutic intervention was performed in 385 (41%), 98% successfully, whereas 91% of detected lesions were tattooed. Significant adverse events occurred in < 1%. ESGE major KPIs by intention to treat (result/target) were: approved indication (94%/95%), depth-of-insertion tattoo (64%/80%), lesion detection (59%/50%-70%), lesion marking (91%/95%), complications (3.3%/< 5%), and adequate comfort (98%/> 90%). All minor KPIs were met. KPIs were consistent between both high-volume Irish-centers and were comparable to the three high-volume UK centers published in the recent DEEP-UK study, all of which performed better than lower-volume UK centers. Conscious sedation was used predominantly in our cohort with acceptable outcomes. Conclusions: DAE requirement is increasing. Our study suggests that a high-volume model ensures compliance with international KPIs. These data also suggest that conscious sedation is a viable option for the majority of DAEs without reducing effectiveness, while maintaining comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.